# Prognostic Predictors of Response to Hypoglycemic Therapy

Study · id `cardio:ct-nct03804411` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03804411](<https://clinicaltrials.gov/study/NCT03804411>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03804411

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 800 participants.

## Technical summary

Registry record NCT03804411. Randomized; single masking; primary purpose basic science. Start 2017-08-01 (actual); primary completion 2020-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose basic science
- Phase: Phase 4
- Enrolled: 800 participants (planned count; ClinicalTrials.gov record NCT03804411, source copy `cardio:ctgov-nct03804411-2020-02-10`, retrieved 2026-10-26)
- Started: 2017-08-01 (actual) (ClinicalTrials.gov record NCT03804411, source copy `cardio:ctgov-nct03804411-2020-02-10`, retrieved 2026-10-26)
- Primary completion: 2020-03 (anticipated) (ClinicalTrials.gov record NCT03804411, source copy `cardio:ctgov-nct03804411-2020-02-10`, retrieved 2026-10-26)
- Completion: 2020-05 (anticipated) (ClinicalTrials.gov record NCT03804411, source copy `cardio:ctgov-nct03804411-2020-02-10`, retrieved 2026-10-26)
- Countries: Russia (ClinicalTrials.gov record NCT03804411, source copy `cardio:ctgov-nct03804411-2020-02-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03804411-2020-02-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Prognostic Predictors of Response to Hypoglycemic Therapy
- Condition: Diabetes Mellitus, Type 2
- Intervention (Drug): Automatic system guided treatment
- Intervention (Drug): Standard treatment
- Lead sponsor: Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: cfd90126218ada2b655462012f5e9ee54ec3f6a88c660c654c45ade701dd1d3b
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
